Inflammatory pseudotumor causing small bowel obstruction and mimicking lymphoma in a patient with AIDS: Clinical improvement after initiation of thalidomide treatment

Clinical Infectious Diseases

Volumn 30, Issue 5, 2000, Pages 826-831

  Aboulafia, D M ^a  

^a VIRGINIA MASON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THALIDOMIDE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; LYMPHOMA; MALE; PRIORITY JOURNAL; PSEUDOTUMOR; SMALL INTESTINE OBSTRUCTION; SYMPTOMATOLOGY; TREATMENT OUTCOME; WASTING SYNDROME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTI-HIV AGENTS; CASE REPORT; DIAGNOSIS, DIFFERENTIAL; GRANULOMA, PLASMA CELL; HUMAN; INTESTINAL OBSTRUCTION; INTESTINE, SMALL; LYMPHOMA, AIDS-RELATED; MALE; RECEPTORS, TUMOR NECROSIS FACTOR; THALIDOMIDE; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR;

EID: 0033806803     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/313768     Document Type: Article

References (34)

1. Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor): A clinico-pathologic and immunohistochemical study of 84 cases
2. The pulmonary plasma cell/histiocytoma complex
3. Angioinvasive plasma cell granulomas of the lung
4. Myofibroblasts in human granulation tissue
5. Inflammatory pseudotumor of lymph nodes: A distinctive pattern of nodal reaction
6. Sclerosing mesenteritis, mesenteric panniculitis and mesenteric lipodystrophy: A single entity?
7. Thalidomide in diseases associated with human immunodeficiency virus infection
8. Acute-phase proteins and other systemic responses to inflammation
9. Thalidomide exerts its inhibitory action on tumor necrosis factor-α by enhancing mRNA degradation
10. Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group
11. Cutaneous inflammatory pseudotumor: Lesions resembling 'inflammatory pseudotumors' or 'plasma cell granulomas' of extracutaneous sites
12. Inflammatory pseudotumor of lymph nodes. Additional observations and evidence for an inflammatory etiology
13. Sclerosing mesenteritis: An unusual cause of abdominal pain in an HIV-positive patient
14. Retroperitoneal fibrosis treated with tamoxifen
15. Effects of thalidomide on HIV-associated wasting syndrome: A randomized, double-blind, placebo-controlled clinical trial
16. Inflammatory pseudotumor of lymph nodes: A distinctive pattern of nodal reaction
17. Angiomatoid malignant fibrous histiocytoma: A follow-up study of 108 cases with evaluation of possible predictors of outcome
18. Interleukin-6 but not interleukin-4 is expressed in Reed-Sternberg cells in Hodgkin's disease with or without features of Castleman's disease
19. Functional heterogeneity and pathogenic significance of interleukin-6 in B-cell lymphomas
20. Retroviral-mediated transfer of interleukin-6 into hematopoietic cells of mice results in a syndrome resembling Castleman's disease
21. Castleman's disease, Kaposi's sarcoma and immunoblastic non-Hodgkin's lymphoma occurring in a patient with AIDS: A case report with speculations on pathogenesis
22. Brief report: Alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody
23. Thalidomide revisited
24. Antitumor activity of thalidomide in refractory multiple myeloma
25. Thalidomide for treatment of oral aphthous ulcers in patients with human immunodeficiency virus: Case report and review
26. + individuals
27. Successful treatment of idiopathic colitis and proctitis using thalidomide in persons infected with human immunodeficiency virus
28. Thalidomide in painful AIDS-associated proctitis
29. Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome
30. Treatment of wasting in patients with acquired immunodeficiency syndrome
31. The effect of thalidomide on the pathogenesis of human immunodeficiency virus type I and M. tuberculosis infection
32. Thalidomide and thalidomide analogs reduce HIV type I replication in human macrophages in vitro
33. Thalidomide inhibits the replication of human immunodeficiency virus type I
34. Mycobacterial spindle cell pseudotumor of lymph nodes